Mouse model-based studies of targeting serine/threonine kinase mammalian target of rapamycin (mTOR) have provided several key insights into the role of mTOR-dependent signaling pathway in the pathogenesis of allergic asthma. This evidence concerns the gene MTOR and allergic asthma.